Publications by authors named "Manuel Modiano"

Claim this Profile
S
Safety and Efficacy of Same-Day Administration of Eflapegrastim in Patients with Early-Stage Breast Cancer Receiving Chemotherapy.
Manuel Modiano, Shanta Chawla, Jeffrey L Vacirca, Kenneth Crist, Howard Franklin

Oncologist· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
Darren Pan, Jonathan L Kaufman, Myo Htut, Manish Agrawal, Amitabha Mazumder, Manuel R Modiano

Cancer Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Daniel P Petrylak, Nicholas J Vogelzang, Kamal Chatta, Mark T Fleming, David C Smith, Manuel Modiano

Prostate· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.
Lecia V Sequist, Jhanelle Elaine Gray, Wael A Harb, Ariel Lopez-Chavez, Robert C Doebele, Manuel R Modiano

Oncologist· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma.
Imane El Dika, Ho Yeong Lim, Wei Peng Yong, Chia-Chi Lin, Jung-Hwan Yoon, Manuel Modiano

Oncologist· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC.
Corey J Langer, Edward S Kim, Eric C Anderson, Robert M Jotte, Manuel Modiano

Front Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma.
Steven J Cohen, Mark M Zalupski, Paul Conkling, Francis Nugent, Wen Wee Ma, Manuel Modiano

Am J Clin Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
Richard Derman, Eloy Roman, Manuel R Modiano, Maureen M Achebe, Lars L Thomsen

Am J Hematol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
Paul J Hesketh, Ian D Schnadig, Lee S Schwartzberg, Manuel R Modiano, Karin Jordan

Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
Lee S Schwartzberg, Manuel R Modiano, Bernardo L Rapoport, Martin R Chasen, Cesare Gridelli

Lancet Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
Bernardo L Rapoport, Martin R Chasen, Cesare Gridelli, Laszlo Urban, Manuel R Modiano

Lancet Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
Ralph G Zinner, Coleman K Obasaju, David R Spigel, Robert W Weaver, J Thaddeus Beck, Manuel R Modiano

J Thorac Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.
Johanna C Bendell, Heinz-Josef Lenz, Theresa Ryan, Bassel F El-Rayes, John L Marshall, Manuel R Modiano

Invest New Drugs· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
John R Mackey, Miguel Martin, Tadeusz Pienkowski, Janusz Rolski, Jean-Paul Guastalla, Manuel R Modiano

Lancet Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.
Tomasz P Srokowski, James E Liebmann, Manuel R Modiano, Gary I Cohen, Barbara Pro

Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
Steven J Cohen, Mark M Zalupski, Manuel R Modiano, Paul Conkling, Yehuda Z Patt

Cancer Chemother Pharmacol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer.
David Loesch, F Anthony Greco, Neil N Senzer, Howard A Burris, John D Hainsworth, Manuel R Modiano

J Clin Oncol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of imexon in patients with advanced malignancy.
Tomislav Dragovich, Michael Gordon, David Mendelson, Lucas Wong, Manuel Modiano

J Clin Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
Ghassan K Abou-Alfa, Richard Letourneau, Graydon Harker, Manuel Modiano, Herbert Hurwitz

J Clin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer.
Jacob M Estes, Charles A Leath, Sybilann Williams, Manuel R Modiano, Michael Sawyer

Gynecol Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study.
Lisa K Hansen, Polly Feigl, Manuel R Modiano, Jose A Lopez, Sylvia Escobedo Sluder

Cancer Nurs· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant docetaxel for node-positive breast cancer.
Miguel Martin, Tadeusz Pienkowski, John Mackey, Marek Pawlicki, Jean-Paul Guastalla, Manuel Modiano

N Engl J Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer.
John Murren, Manuel Modiano, Shivaani Kummar, Caroline Clairmont, Merrill Egorin

Invest New Drugs· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
Miguel A Villalona-Calero, Paul Ritch, Jose A Figueroa, Gregory A Otterson, Robert Belt, Manuel Modiano

Clin Cancer Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
John Murren, Manuel Modiano, Caroline Clairmont, Paula Lambert, Niramol Savaraj

Clin Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis